in the United Kingdom
The ambition of Sanofi is to become
a diversified global healthcare leader,
focused on patients' needs.
Sanofi Group in the United Kingdom
The ambition of Sanofi is to become a diversified global healthcare leader, focused on patients' needs.
Sanofi UK, a subsidiary of the global pharmaceutical company Sanofi, is a dynamic, rapidly evolving organisation that is working to meet the needs of healthcare professionals and their patients.
This website explains our company background, values and products. There are also details of the therapy areas we specialise in and latest company news.
As well as updates on the latest developments, you’ll find details of what we do, the exciting career opportunities we offer and the initiatives we undertake as part of our wider humanitarian responsibility to promote health.
Sanofi is the fourth largest pharmaceutical company in the world and the largest in emerging markets.
With more than 100,000 employees in 110 countries, Sanofi has core strengths in the field of healthcare: a worldwide presence, market leadership in vaccines, major biological products and a strong and long-established presence in emerging markets.
Company business activities also include consumer healthcare products, generics and animal health products.
We hope this website gives you an enjoyable introduction to Sanofi in the UK, but if you have any questions or would like any additional information, please feel free to contact us.
Thank you for taking the time to visit the Sanofi UK website
One Onslow Street
Tel: 01483 505 515
Fax: 01483 535 432
Sanofi Diabetes Products
If you have any questions relating to any of Sanofi's diabetes products or services, or experience difficulty in getting supply of any Sanofi diabetes products,
Sanofi in the UK
February 28, 2013
Information for Healthcare Professionals in the UK relating to the supply of Sanofi products
The Forgotten 10,000 - Getting it Right for Men with Prostate Cancer
Sanofi hosts QiC Programme Awards
Public Declaration of Payments for Healthcare Professionals
2013 Patient Group Bursary
May 01, 2013
Lyxumia▼® (lixisenatide) - effective new Type 2 diabetes treatment could save the NHS millions offering value and choice
March 15, 2013
Sanofi Diabetes announces today £10,000 funding for projects to support optimum diabetes management
March 06, 2013
Sanofi Launches 2013 Patient Group Bursary Scheme and Demonstrates Ongoing Commitment to Patient Empowerment